{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,25]],"date-time":"2026-04-25T23:37:25Z","timestamp":1777160245179,"version":"3.51.4"},"reference-count":33,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"7","content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":["Pancreas"],"published-print":{"date-parts":[[2022,8]]},"abstract":"<jats:sec>\n            <jats:title>Objectives<\/jats:title>\n            <jats:p>Current guidelines limit pancreatic cancer screening to those <jats:italic toggle=\"yes\">BRCA1\/2<\/jats:italic> patients who have a family history of pancreatic cancer. We aimed to assess the association between family history and risk of pancreatic neoplasms in <jats:italic toggle=\"yes\">BRCA1\/2<\/jats:italic> patients.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Methods<\/jats:title>\n            <jats:p>We reviewed medical records of <jats:italic toggle=\"yes\">BRCA1\/2<\/jats:italic> patients followed at our institution between 1995 and 2020. Family history was defined as those with a first-degree relative with pancreatic cancer. We compared the incidence and prevalence of pancreatic neoplasms between patients with and without family history of pancreatic cancer.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Results<\/jats:title>\n            <jats:p>We identified 56 <jats:italic toggle=\"yes\">BRCA1\/2<\/jats:italic> patients with family history and 238 without family history of pancreatic cancer. No difference between these groups was noted in age, race, or sex. Mean follow-up interval for <jats:italic toggle=\"yes\">BRCA1\/2<\/jats:italic> patients was 4.6 years (range, 0\u201319.7 years). There was no significant difference in prevalence (19.6% vs 12.6; <jats:italic toggle=\"yes\">P<\/jats:italic> = 0.3) or incidence (29% vs 14.1%; <jats:italic toggle=\"yes\">P<\/jats:italic> = 0.08) of branch-duct intraductal papillary mucinous neoplasm between the 2 groups. No association between family history and pancreatic cancer risk was noted. Only 1 of 10 <jats:italic toggle=\"yes\">BRCA1\/2<\/jats:italic> patients with pancreatic cancer had a family history.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Conclusions<\/jats:title>\n            <jats:p>Our results do not support using family history to determine eligibility for pancreatic cancer screening.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1097\/mpa.0000000000002104","type":"journal-article","created":{"date-parts":[[2022,11,17]],"date-time":"2022-11-17T15:13:30Z","timestamp":1668698010000},"page":"733-738","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":8,"title":["Association Between Family History and Risk of Pancreatic Cancer in Patients With BRCA1 and BRCA2 Pathogenic Variants"],"prefix":"10.1097","volume":"51","author":[{"given":"Ishani","family":"Shah","sequence":"first","affiliation":[{"name":"Division of Gastroenterology, Department of Medicine"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Andy","family":"Silva-Santisteban","sequence":"additional","affiliation":[{"name":"Division of Gastroenterology, Department of Medicine"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Katharine A.","family":"Germansky","sequence":"additional","affiliation":[{"name":"Division of Gastroenterology, Department of Medicine"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Cinthana","family":"Kandasamy","sequence":"additional","affiliation":[{"name":"Department of Medicine, Beth Israel Deaconess Medical Center and Harvard Medical School, Boston, MA."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jack","family":"Mlabasati","sequence":"additional","affiliation":[{"name":"Department of Medicine, Beth Israel Deaconess Medical Center and Harvard Medical School, Boston, MA."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dora C.","family":"Huang","sequence":"additional","affiliation":[{"name":"Department of Medicine, Beth Israel Deaconess Medical Center and Harvard Medical School, Boston, MA."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Vaibhav","family":"Wadhwa","sequence":"additional","affiliation":[{"name":"Division of Gastroenterology, Department of Medicine"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mohammad","family":"Bilal","sequence":"additional","affiliation":[{"name":"Division of Gastroenterology, Department of Medicine"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mandeep S.","family":"Sawhney","sequence":"additional","affiliation":[{"name":"Division of Gastroenterology, Department of Medicine"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","reference":[{"key":"bib1-20250808","doi-asserted-by":"crossref","first-page":"699","DOI":"10.1038\/nrgastro.2009.177","article-title":"Epidemiology of pancreatic cancer: an overview","volume":"6","year":"2009","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"bib2-20250808","first-page":"7","article-title":"Cancer statistics, 2020","volume":"70","year":"2020","journal-title":"CA Cancer J Clin"},{"key":"bib3-20250808","doi-asserted-by":"crossref","first-page":"2913","DOI":"10.1158\/0008-5472.CAN-14-0155","article-title":"Projecting cancer incidence and deaths to 2030: the unexpected burden of thyroid, liver, and pancreas cancers in the United States","volume":"74","year":"2014","journal-title":"Cancer Res"},{"key":"bib4-20250808","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1097\/00000658-200301000-00011","article-title":"Prognostic factors following curative resection for pancreatic adenocarcinoma: a population-based, linked database analysis of 396 patients","volume":"237","year":"2003","journal-title":"Ann Surg"},{"key":"bib5-20250808","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1136\/gutjnl-2019-319352","article-title":"Management of patients with increased risk for familial pancreatic cancer: updated recommendations from the International Cancer of the Pancreas Screening (CAPS) Consortium","volume":"69","year":"2020","journal-title":"Gut"},{"key":"bib6-20250808","doi-asserted-by":"crossref","first-page":"438","DOI":"10.1001\/jama.2019.10232","article-title":"Screening for pancreatic cancer: US Preventive Services Task Force reaffirmation recommendation statement","volume":"322","year":"2019","journal-title":"JAMA"},{"key":"bib7-20250808","doi-asserted-by":"crossref","first-page":"740","DOI":"10.1053\/j.gastro.2018.05.035","article-title":"Risk of neoplastic progression in individuals at high risk for pancreatic cancer undergoing long-term surveillance","volume":"155","year":"2018","journal-title":"Gastroenterology"},{"key":"bib8-20250808","doi-asserted-by":"crossref","first-page":"2010","DOI":"10.1200\/JCO.2015.64.0730","article-title":"Benefit of surveillance for pancreatic cancer in high-risk individuals: outcome of long-term prospective follow-up studies from three European expert centers","volume":"34","year":"2016","journal-title":"J Clin Oncol"},{"key":"bib9-20250808","doi-asserted-by":"crossref","first-page":"1152","DOI":"10.1126\/science.aam7344","article-title":"PARP inhibitors: synthetic lethality in the clinic","volume":"355","year":"2017","journal-title":"Science"},{"key":"bib10-20250808","doi-asserted-by":"crossref","first-page":"1132","DOI":"10.1038\/bjc.2014.418","article-title":"Overall survival and clinical characteristics of pancreatic cancer in BRCA mutation carriers","volume":"111","year":"2014","journal-title":"Br J Cancer"},{"key":"bib11-20250808","doi-asserted-by":"crossref","first-page":"1378","DOI":"10.1200\/JCO.19.02931","article-title":"Randomized, multicenter, phase II trial of gemcitabine and cisplatin with or without veliparib in patients with pancreas adenocarcinoma and a germline BRCA\/PALB2 mutation","volume":"38","year":"2020","journal-title":"J Clin Oncol"},{"key":"bib12-20250808","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1056\/NEJMoa1903387","article-title":"Maintenance olaparib for germline BRCA-mutated metastatic pancreatic cancer","volume":"381","year":"2019","journal-title":"N Engl J Med"},{"key":"bib13-20250808","doi-asserted-by":"crossref","first-page":"3963","DOI":"10.1245\/s10434-020-08469-8","article-title":"Increased rate of complete pathologic response after neoadjuvant FOLFIRINOX for BRCA mutation carriers with borderline resectable pancreatic cancer","volume":"27","year":"2020","journal-title":"Ann Surg Oncol"},{"key":"bib14-20250808","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1038\/ajg.2014.435","article-title":"ACG clinical guideline: genetic testing and management of hereditary gastrointestinal cancer syndromes","volume":"110","year":"2015","journal-title":"Am J Gastroenterol"},{"key":"bib15-20250808","doi-asserted-by":"crossref","first-page":"2651","DOI":"10.1093\/annonc\/mdt280","article-title":"Family history of cancer and the risk of cancer: a network of case-control studies","volume":"24","year":"2013","journal-title":"Ann Oncol"},{"key":"bib16-20250808","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1007\/s10689-008-9214-8","article-title":"Family history is a significant risk factor for pancreatic cancer: results from a systematic review and meta-analysis","volume":"8","year":"2009","journal-title":"Fam Cancer"},{"key":"bib17-20250808","article-title":"Incidence and prevalence of intraductal papillary mucinous neoplasms in individuals with BRCA1 and BRCA2 pathogenic variant. J Clin Gastroenterol","year":"2022"},{"key":"bib18-20250808","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1016\/j.jbi.2008.08.010","article-title":"Research Electronic Data Capture (REDCap)\u2014a metadata-driven methodology and workflow process for providing translational research informatics support","volume":"42","year":"2009","journal-title":"J Biomed Inform"},{"key":"bib19-20250808","first-page":"1067","article-title":"Multifocal neoplastic precursor lesions associated with lobular atrophy of the pancreas in patients having a strong family history of pancreatic cancer","volume":"30","year":"2006","journal-title":"Am J Surg Pathol"},{"key":"bib20-20250808","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1016\/j.yasu.2010.05.011","article-title":"Update on familial pancreatic cancer","volume":"44","year":"2010","journal-title":"Adv Surg"},{"key":"bib21-20250808","doi-asserted-by":"crossref","first-page":"1726","DOI":"10.14309\/ajg.0000000000000262","article-title":"Pancreatic steatosis: an emerging clinical entity","volume":"114","year":"2019","journal-title":"Am J Gastroenterol"},{"key":"bib22-20250808","doi-asserted-by":"crossref","first-page":"3013","DOI":"10.1111\/cas.13766","article-title":"Fatty pancreas: a possible risk factor for pancreatic cancer in animals and humans","volume":"109","year":"2018","journal-title":"Cancer Sci"},{"key":"bib23-20250808","doi-asserted-by":"crossref","first-page":"763","DOI":"10.3390\/jcm11030763","article-title":"Fatty pancreas and pancreatic cancer: an overlooked association?","volume":"11","year":"2022","journal-title":"J Clin Med"},{"key":"bib24-20250808","doi-asserted-by":"crossref","first-page":"911","DOI":"10.1016\/j.jacr.2017.03.010","article-title":"Management of incidental pancreatic cysts: a white paper of the ACR Incidental Findings Committee","volume":"14","year":"2017","journal-title":"J Am Coll Radiol"},{"key":"bib25-20250808","doi-asserted-by":"crossref","first-page":"738","DOI":"10.1016\/j.pan.2017.07.007","article-title":"Revisions of international consensus Fukuoka guidelines for the management of IPMN of the pancreas","volume":"17","year":"2017","journal-title":"Pancreatology"},{"key":"bib26-20250808","doi-asserted-by":"crossref","first-page":"1686","DOI":"10.21105\/joss.01686","article-title":"Welcome to the tidyverse","volume":"4","year":"2019","journal-title":"J Open Source Softw"},{"key":"bib27-20250808","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1093\/jnci\/djp466","article-title":"Importance of age of onset in pancreatic cancer kindreds","volume":"102","year":"2010","journal-title":"J Natl Cancer Inst"},{"key":"bib28-20250808","doi-asserted-by":"crossref","first-page":"2005","DOI":"10.1038\/bjc.2012.483","article-title":"The incidence of pancreatic cancer in BRCA1 and BRCA2 mutation carriers","volume":"107","year":"2012","journal-title":"Br J Cancer"},{"key":"bib29-20250808","doi-asserted-by":"crossref","first-page":"777","DOI":"10.1002\/jso.25376","article-title":"Are BRCA1 and BRCA2 gene mutation patients underscreened for pancreatic adenocarcinoma?","volume":"119","year":"2019","journal-title":"J Surg Oncol"},{"key":"bib30-20250808","first-page":"5619358","article-title":"Frequency and significance of abnormal pancreatic imaging in patients with BRCA1 and BRCA2 genetic mutations","volume":"2016","year":"2016","journal-title":"Scientifica (Cairo)"},{"key":"bib31-20250808","doi-asserted-by":"crossref","first-page":"1067","DOI":"10.1093\/jnci\/djy024","article-title":"Prospective evaluation of germline alterations in patients with exocrine pancreatic neoplasms","volume":"110","year":"2018","journal-title":"J Natl Cancer Inst"},{"key":"bib32-20250808","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1200\/JCO.18.01489","article-title":"Evaluating susceptibility to pancreatic cancer: ASCO provisional clinical opinion","volume":"37","year":"2019","journal-title":"J Clin Oncol"},{"key":"bib33-20250808","doi-asserted-by":"crossref","first-page":"697","DOI":"10.1038\/bjc.2017.19","article-title":"Overall survival and clinical characteristics of BRCA mutation carriers with stage I\/II pancreatic cancer","volume":"116","year":"2017","journal-title":"Br J Cancer"}],"container-title":["Pancreas"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/MPA.0000000000002104","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,8,8]],"date-time":"2025-08-08T11:04:21Z","timestamp":1754651061000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/MPA.0000000000002104"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,8]]},"references-count":33,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2022]]}},"URL":"https:\/\/doi.org\/10.1097\/mpa.0000000000002104","relation":{},"ISSN":["1536-4828","0885-3177"],"issn-type":[{"value":"1536-4828","type":"electronic"},{"value":"0885-3177","type":"print"}],"subject":[],"published":{"date-parts":[[2022,8]]}}}